breast cancer

Wash U. Research Findings Could Be Good News To Some Breast Cancer Patients

Julie Bierach — Fri, 07 Dec 2012 20:31:23 +0000

The findings of new breast cancer research from Washington University could result in effective treatment for 4,000 additional patients in the United States each year. Scientists made the discovery after analyzing DNA sequencing data from 1,500 patients.

The research appears in the latest edition of Cancer Discovery.

So what does this research mean?

In Depth: British Adventurer Completes 1,000 Mile Swim In St. Louis

Alex Heuer, Mary Edwards and Don Marsh — Mon, 08 Oct 2012 20:51:46 +0000

Dave Cornthwaite is a remarkable British adventurer and he just completed a 1,000 mile swim down the Missouri River, ending in St.

British Swimmer Completes 1,000 Mile Swim Down Missouri, Mississippi River

Tim Lloyd — Sat, 06 Oct 2012 21:38:08 +0000

Update: Dave was interviewed by Don Marsh on St. Louis on the Air on Monday. You can listen to that conversation by clicking here.

This morning The Gateway Arch was the last stop on British swimmer Dave Cornthwaite’s 1000-mile journey down the Missouri River, completing the last few miles on the Mississippi River.

New research could lead to better treatment for some types of breast cancer

Tim Lloyd — Mon, 24 Sep 2012 00:04:48 +0000

Researchers at Washington University used new technology to unravel the entire genetic helix for a subset of breast cancer, called basal-like, and found that it is more like ovarian cancer than other types of breast cancer.

The study’s co-Leader, Mathew Ellis, said that means techniques used to tackle ovarian cancer could be more effective than traditional methods for basal-like breast cancer.

“The more we understand about an individual breast cancer the more we can actually treat the patient accurately,” Ellis said. “I like to call this genome forward medicine.”

Morning headlines - Monday, June 11, 2012

Rachel Lippmann and Tim Lloyd — Mon, 11 Jun 2012 11:35:30 +0000

Finding from Washington University could hold key to more targeted breast cancer treatments

Researchers at Washington University have uncovered a genetic mutation that explains why some women don't respond to a common form of breast cancer treatment.

Before surgery, most women with breast cancer receive aromatase inhibitors, which reduce the production of estrogen to shrink the size of tumors. But it doesn't always work.